Conference Coverage

Tomatoes Boosted Low HDL in Small Study


 

AT THE ANNUAL MEETING OF THE ENDOCRINE SOCIETY

HOUSTON – Consuming two midsize uncooked tomatoes daily for a month resulted in a mean 5 mg/dL gain in HDL cholesterol level in a randomized trial in patients with low HDL.

A control group assigned to eat an equal quantity of cucumber – 300 g/day – saw no change in HDL, according to Dr. Daniel Cuevas Ramos of the National Institute of Medical Sciences and Nutrition in Mexico City.

He reported on 41 women and 11 men with low HDL but normal triglyceride levels who participated in the month-long randomized trial, during which they consumed an isocaloric diet.

Over the course of 1 month of follow-up, mean HDL levels in the tomato eaters climbed from 36.5 mg/dL at baseline to 41.6 mg/dL, while the cucumber-eating controls saw no significant change over time.

A linear regression analysis adjusted for age, sex, waist-to-hip ratio, physical activity, body mass index, and intake of alcohol, simple sugars, and omega-3 fatty acids showed that tomato consumption was independently associated with the increase in HDL.

Two medium tomatoes contain about 30 mg of lycopene, the nutrient thought responsible for the HDL boost. Prior cross-sectional studies had linked lycopene intake to higher HDL, he noted.

Dr. Cuevas Ramos reported having no financial conflicts.

Recommended Reading

Statin Doesn't Impair Colesevelam's Glucose-Lowering Ability
MDedge Endocrinology
Myopathy Presenting at Initiation of Statins May Have Another Cause
MDedge Endocrinology
Chronic Kidney Disease, Diabetes Equivalent MI Predictors
MDedge Endocrinology
Newer Lipid Markers Useless for CVD Risk Prediction
MDedge Endocrinology
Meta-Analysis: Statins Don't Prevent Stroke, Death in Women
MDedge Endocrinology
Will ATP IV Spell the End of Cholesterol Targets?
MDedge Endocrinology
Metabolic Syndrome Spurs CVD Risk in Hispanic Women
MDedge Endocrinology
CTA Tracks Plaque Volume Changes With Statin Therapy
MDedge Endocrinology
Last 20 Years: U.S. Youth Lipid Profiles Have Improved
MDedge Endocrinology
Scant Data for Lomitapide May Sidetrack Advisory Committee Review
MDedge Endocrinology